Balloon-occluded retrograde transvenous obliteration in patients with liver cirrhosis and variceal transformation of gastric veins: first experiences of Botkin hospital
https://doi.org/10.16931/1995-5464.2024-4-25-33
Abstract
Aim. To analyze first experiences and demonstrate the results of balloon-occluded retrograde transvenous obliteration in patients with liver cirrhosis and variceal transformation of the gastric veins.
Materials and methods. In the period from November 2023 to August 2024, balloon-occluded retrograde transvenous obliteration was performed on six male patients with liver cirrhosis and gastric varices for secondary prevention of bleeding. The mean age of the patients comprised 56.5 years. Significant gastrorenal shunt and predominantly right-sided drainage of gastroesophageal varices were considered technical indications for the procedure.
Results. No fatalities or complications necessitating reoperation were reported. The follow-up period revealed no recurrences of bleeding. The overall survival rate over six months comprised 100%. Progression of gastric varices was noted in two out of six patients: one patient underwent a repeat procedure, while the other underwent liver transplantation.
Conclusion. Balloon-occluded retrograde transvenous obliteration is recognized as a safe and effective radiological intervention for addressing complications associated with portal hypertension. However, it obtains several limitations and potential adverse effects, which necessitate careful monitoring during follow-up.
About the Authors
A. V. ShabuninRussian Federation
Aleksey V. Shabunin – Doct. of Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, the Head of the S.P. Botkin City Clinical Hospital of Moscow Healthcare Department; Chair of Surgery Department of the Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation.
5, 2nd Botkinsky pr., Moscow, 125284; 2/1 bld. 1, Barrikadnaya str., Moscow, 125993
Z. A. Bagatelia
Russian Federation
Zurab A. Bagatelia – Doct. of Sci. (Med.), Surgeon, Oncologist, Professor of Surgery Department of the Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation; Leading Researcher, First Deputy Director for Medicine of the S.P. Botkin City Clinical Hospital of Moscow Healthcare Department.
5, 2nd Botkinsky pr., Moscow, 125284; 2/1 bld. 1, Barrikadnaya str., Moscow, 125993
V. V. Bedin
Russian Federation
Vladimir V. Bedin – Doct. of Sci. (Med.), Deputy Director of the S.P. Botkin City Clinical Hospital of Moscow Healthcare Department; Professor, Surgery Department of Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation.
5, 2nd Botkinsky pr., Moscow, 125284; 2/1 bld. 1, Barrikadnaya str., Moscow, 125993
P. A. Drozdov
Russian Federation
Pavel A. Drozdov – Doct. of Sci. (Med.), Deputy Director for Research of the S.P. Botkin City Clinical Hospital of Moscow Healthcare Department.
5, 2nd Botkinsky pr., Moscow, 125284; 2/1 bld. 1, Barrikadnaya str., Moscow, 125993
O. N. Levina
Russian Federation
Oksana N. Levina – Cand. of Sci. (Med.), Head of the Gastrohepatopancreatology Unit of the S.P. Botkin City Clinical Hospital of Moscow Healthcare Department.
5, 2nd Botkinsky pr., Moscow, 125284
V. A. Tsurkan
Russian Federation
Vladimir A. Tsurkan – Interventional Radiologist of the S.P. Botkin City Clinical Hospital of Moscow Healthcare Department.
5, 2nd Botkinsky pr., Moscow, 125284
S. A. Astapovich
Russian Federation
Sergey A. Astapovich – Surgeon of the S.P. Botkin City Clinical Hospital of Moscow Healthcare Department.
5, 2nd Botkinsky pr., Moscow, 125284
E. A. Lidzhieva
Russian Federation
Elza A. Lidzhieva – Resident, Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation.
5, 2nd Botkinsky pr., Moscow, 125284
References
1. Asrani S.K., Devarbhavi H., Eaton J., Kamath P.S. Burden of liver diseases in the world. J. Hepatol. 2018; 70 (1): 151–171. https://doi.org/10.1016/j.jhep.2018.09.014
2. Amitrano L., Guardascione M.A., Manguso F., Bennato R., Bove A., DeNucci C., Lombardi G., Martino R., Menchise A., Orsini L., Picascia S., Riccio E. The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am. J. Gastroenterol. 2012; 107 (12): 1872–1878. https://doi.org/10.1038/ajg.2012.313
3. Rodge G.A., Goenka U., Goenka M.K. Management of refractory variceal bleed in cirrhosis. J. Clin. Exp. Hepatol. 2022; 12 (2): 595–602. https://doi.org/10.1016/j.jceh.2021.08.030
4. Khakwani A., Trivedi M., Afzal M., Kahlon P., Khola Patel P., Chirumamilla P.C., Vohra R.R., Ratheesh R., Mathew M., Abdin Z.U., Nazir Z. Use of Balloon Occluded Retrograde Transvenous Obliteration (BRTO) for treatment of gastric varices: a narrative review. Cureus. 2023; 15 (4): e38233. https://doi.org/10.7759/cureus.38233
5. Manukyan G.V., Shertsinger A.G., Zhigalova S.B., Semenova T.S., Martirosyan R.A. Primary prevention of bleeding from esophageal and gastric varices in patients with portal hypertension. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2016; 21 (2): 93–104. https://doi.org/10.16931/1995-5464.2016293-104 (In Russian)
6. Choi Y.H., Yoon C.J., Park J.H., Chung J.W., Kwon J.W., Choi G.M. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J. Radiol. 2003; 4 (2): 109–116. https://doi.org/10.3348/kjr.2003.4.2.109
7. Kanagawa H., Mima S., Kouyama H., Gotoh K., Uchida T., Okuda K. Treatment of gastric fundal varices by balloonoccluded retrograde transvenous obliteration. J. Gastroenterol. Hepatol. 1996; 11 (1): 51–58. http://doi.org/10.1111/j.1440-1746.1996.tb00010.x
8. Sabri S.S., Saad W.E. Anatomy and classification of gastrorenal and gastrocaval shunts. Semin. Intervent. Radiol. 2011; 28 (3): 296–302. https://doi.org/10.1055/s-0031-1284456
9. Manukyan G.V., Malov S.L., Musin R.A., Ghigalova S.B., Lebezev V.M., Kitsenko E.A., Fandeev E.E. First experience of balloon-occluded retrograde transvenous obliteration of gastric varices. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2022; 27 (2): 58–65. https://doi.org/10.16931/1995-5464.2022-2-58-64 (In Russian)
10. Shabunin A.V., Bedin V.V., Drozdov P.A., Levina O.N., Tsurkan V.A., Zhuravel O.S. First experience of transjugular intrahepatic portosystemic shunting at multidisciplinary hospital with a liver transplantation program. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2022; 27 (1): 48–55. https://doi.org/10.16931/1995-5464.2022-1-48-55 (In Russian)
11. Shabunin A.V., Bedin V.V., Drozdov P.A., Levina O.N., Tsurkan V.A., Zhuravel O.S., Astapovich S.A. The first experience of partial spleen embolization for the correction of thrombocytopenia in patients with liver cirrhosis. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2021; 26 (3): 97–103. https://doi.org/10.16931/1995-5464.2021-3-97-103 (In Russian)
12. Bagatelija Z.A., Duhanina I.V. Analysis of surgical care for patients with diseases of the abdominal organs. Vrach-aspirant. 2015; 69 (2.2): 208–212. (In Russian)
13. Wang Z.W., Liu J.C., Zhao F., Zhang W.G., Duan X.H., Chen P.F., Yang S.F., Li H.W., Chen F.W., Shi H.S., Ren J.Z. Comparison of the effects of TIPS versus BRTO on bleeding gastric varices: a meta-analysis. Can. J. Gastroenterol. Hepatol. 2020; 2020: 5143013. https://doi.org/10.1155/2020/5143013
14. Gimm G., Chang Y., Kim H.C., Shin A., Cho E.J., Lee J.H., Yu S.J., Yoon J.H., Kim Y.J. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for the management of gastric variceal bleeding. Gut Liver. 2018; 12 (6): 704–713. https://doi.org/10.5009/gnl17515
15. Sabri S.S., Abi-Jaoudeh N., Swee W., Saad W.E., Turba U.C., Caldwell S.H., Angle J.F., Matsumoto A.H. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration. J. Vasc. Interv. Radiol. 2014; 25 (3): 355–361. https://doi.org/10.1016/j.jvir.2013.12.001
16. Miyamoto Y., Oho K., Kumamoto M., Toyonaga A., Sata M. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J. Gastroenterol. Hepatol. 2003; 18 (8): 934–942. https://doi.org/10.1046/j.1440-1746.2003.03087.x
Supplementary files
Review
For citations:
Shabunin A.V., Bagatelia Z.A., Bedin V.V., Drozdov P.A., Levina O.N., Tsurkan V.A., Astapovich S.A., Lidzhieva E.A. Balloon-occluded retrograde transvenous obliteration in patients with liver cirrhosis and variceal transformation of gastric veins: first experiences of Botkin hospital. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2024;29(4):25-33. (In Russ.) https://doi.org/10.16931/1995-5464.2024-4-25-33